Par Drugs and Chemicals Limited

Informe acción NSEI:PAR

Capitalización de mercado: ₹2.8b

Par Drugs and Chemicals Dirección

Dirección controles de criterios 3/4

El CEO de Par Drugs and Chemicals' es Jignesh Savani, nombrado en Nov 2018, tiene una permanencia de 5.58 años. posee directamente un 43.2% de las acciones de la empresa, con un valor de ₹1.20B. La antigüedad media del equipo directivo y de la junta directiva es de 5.6 años y 5.9 años, respectivamente.

Información clave

Jignesh Savani

Chief Executive Officer (CEO)

₹5.2m

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO5.6yrs
Participación del CEO43.2%
Permanencia media de la dirección5.6yrs
Promedio de permanencia en la Junta Directiva5.9yrs

Actualizaciones recientes de la dirección

Recent updates

Improved Earnings Required Before Par Drugs and Chemicals Limited (NSE:PAR) Stock's 29% Jump Looks Justified

Apr 16
Improved Earnings Required Before Par Drugs and Chemicals Limited (NSE:PAR) Stock's 29% Jump Looks Justified

Here's Why We Think Par Drugs and Chemicals (NSE:PAR) Might Deserve Your Attention Today

Apr 05
Here's Why We Think Par Drugs and Chemicals (NSE:PAR) Might Deserve Your Attention Today

Do Par Drugs and Chemicals' (NSE:PAR) Earnings Warrant Your Attention?

Nov 03
Do Par Drugs and Chemicals' (NSE:PAR) Earnings Warrant Your Attention?

If EPS Growth Is Important To You, Par Drugs and Chemicals (NSE:PAR) Presents An Opportunity

May 19
If EPS Growth Is Important To You, Par Drugs and Chemicals (NSE:PAR) Presents An Opportunity

Does Par Drugs and Chemicals (NSE:PAR) Deserve A Spot On Your Watchlist?

Mar 17
Does Par Drugs and Chemicals (NSE:PAR) Deserve A Spot On Your Watchlist?

Do Par Drugs and Chemicals's (NSE:PAR) Earnings Warrant Your Attention?

Oct 22
Do Par Drugs and Chemicals's (NSE:PAR) Earnings Warrant Your Attention?

Investors Shouldn't Be Too Comfortable With Par Drugs and Chemicals' (NSE:PAR) Robust Earnings

Aug 11
Investors Shouldn't Be Too Comfortable With Par Drugs and Chemicals' (NSE:PAR) Robust Earnings

Here's Why We Think Par Drugs and Chemicals (NSE:PAR) Is Well Worth Watching

Jul 14
Here's Why We Think Par Drugs and Chemicals (NSE:PAR) Is Well Worth Watching

Is Par Drugs and Chemicals Limited (NSE:PAR) An Attractive Dividend Stock?

Mar 31
Is Par Drugs and Chemicals Limited (NSE:PAR) An Attractive Dividend Stock?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Par Drugs and Chemicals Limited's NSE:PAR) Stock?

Mar 05
Are Strong Financial Prospects The Force That Is Driving The Momentum In Par Drugs and Chemicals Limited's NSE:PAR) Stock?

Chairman of the Board & MD Falgun Savani Just Bought A Handful Of Shares In Par Drugs and Chemicals Limited (NSE:PAR)

Feb 06
Chairman of the Board & MD Falgun Savani Just Bought A Handful Of Shares In Par Drugs and Chemicals Limited (NSE:PAR)

Here's Why I Think Par Drugs and Chemicals (NSE:PAR) Might Deserve Your Attention Today

Jan 10
Here's Why I Think Par Drugs and Chemicals (NSE:PAR) Might Deserve Your Attention Today

How Does Par Drugs and Chemicals Limited (NSE:PAR) Fare As A Dividend Stock?

Dec 13
How Does Par Drugs and Chemicals Limited (NSE:PAR) Fare As A Dividend Stock?

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Jignesh Savani en comparación con los beneficios de Par Drugs and Chemicals?
FechaCompensación totalSalarioIngresos de la empresa
Mar 31 2024n/an/a

₹145m

Dec 31 2023n/an/a

₹142m

Sep 30 2023n/an/a

₹127m

Jun 30 2023n/an/a

₹115m

Mar 31 2023₹5mn/a

₹113m

Dec 31 2022n/an/a

₹103m

Sep 30 2022n/an/a

₹106m

Jun 30 2022n/an/a

₹91m

Mar 31 2022₹5m₹5m

₹92m

Dec 31 2021n/an/a

₹112m

Sep 30 2021n/an/a

₹112m

Jun 30 2021n/an/a

₹115m

Mar 31 2021₹4m₹4m

₹116m

Dec 31 2020n/an/a

₹88m

Sep 30 2020n/an/a

₹83m

Jun 30 2020n/an/a

₹65m

Mar 31 2020₹4mn/a

₹48m

Compensación vs. Mercado: La compensación total de Jignesh($USD62.09K) está por encima de la media de empresas de tamaño similar en el mercado Indian ($USD38.53K).

Compensación vs. Ingresos: La compensación de Jignesh ha sido consistente con los resultados de la empresa en el último año.

CEO

Jignesh Savani (47 yo)

5.6yrs

Permanencia

₹5,180,000

Compensación

Mr. Jignesh Vallabhbhai Savani is Promoter of at Par Drugs and Chemicals Limited and has been its Chief Executive Officer since November 26, 2018 and serves as its Executive Director since February 26, 199...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Falgun Savani
Chairman of the Board & MD25.3yrs₹5.20m21.5%
₹ 592.1m
Jignesh Savani
CEO & Executive Director5.6yrs₹5.18m43.2%
₹ 1.2b
Chintan Chauhan
Chief Financial Officer5.6yrs₹546.00ksin datos
Sanket Trivedi
Company Secretary & Compliance Officer5.8yrs₹630.00ksin datos
Ghanshayambhai Savani
Whole Time Director5.6yrs₹5.18m6.52%
₹ 179.5m

5.6yrs

Permanencia media

47yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de PAR es experimentado (5.6 años antigüedad media).

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Falgun Savani
Chairman of the Board & MD25.3yrs₹5.20m21.5%
₹ 592.1m
Jignesh Savani
CEO & Executive Director25.3yrs₹5.18m43.2%
₹ 1.2b
Ghanshayambhai Savani
Whole Time Director12.2yrs₹5.18m6.52%
₹ 179.5m
Pravin Bhayani
Lead Independent Director5.4yrs₹75.00ksin datos
Kajal Vaghani
Independent Director5.4yrs₹45.00ksin datos
Krishna Shah
Independent Director5.4yrs₹75.00ksin datos
Nayna Savani
Non Executive Director6.3yrs₹45.00k1.54%
₹ 42.4m
Bintal Bhaveshkumar Shah
Independent Director3.8yrs₹25.00ksin datos

5.9yrs

Permanencia media

47yo

Promedio de edad

Junta con experiencia: La junta directiva de PAR se considera experimentada (5.7 años de antigüedad promedio).